Hugo Murua Escobar

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Dietmar Zechner · 5 shared papers, 2022–2024 · strength 0.74
   • Paper Sex Matters-Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer. DOI 10.3390/cancers16101901↗
   • Paper Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice. DOI 10.1016/j.hbpd.2022.12.003↗
   • Paper Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Li… DOI 10.3390/cancers14184467↗
2. Yixuan Ma · 4 shared papers, 2022–2024 · strength 0.59
   • Paper Sex Matters-Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer. DOI 10.3390/cancers16101901↗
   • Paper Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Li… DOI 10.3390/cancers14184467↗
   • Paper The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Panc… DOI 10.3390/ijms23084295↗
3. Georg Fuellen · 3 shared papers, 2020–2024 · strength 0.50
   • Paper Multicohort study testing the generalisability of the SASKit-ML stroke and PDAC prognostic model pipeline to other chro… DOI 10.1136/bmjopen-2024-088181↗
   • Paper Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice. DOI 10.1016/j.hbpd.2022.12.003↗
   • Paper Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidi… DOI 10.1136/bmjopen-2020-039560↗
4. Frank Ulrich Weiß · 3 shared papers, 2022 · strength 0.40
   • Paper Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Li… DOI 10.3390/cancers14184467↗
   • Paper The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Panc… DOI 10.3390/ijms23084295↗
   • Paper Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in… DOI 10.3390/ijms23084409↗
5. Markus M. Lerch · 3 shared papers, 2022 · strength 0.40
   • Paper Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Li… DOI 10.3390/cancers14184467↗
   • Paper The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Panc… DOI 10.3390/ijms23084295↗
   • Paper Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in… DOI 10.3390/ijms23084409↗
6. Robert Jaster · 3 shared papers, 2020–2023 · strength 0.38
   • Paper Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice. DOI 10.1016/j.hbpd.2022.12.003↗
   • Paper Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Li… DOI 10.3390/cancers14184467↗
   • Paper Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidi… DOI 10.1136/bmjopen-2020-039560↗
7. Larissa Henze · 2 shared papers, 2020–2024 · strength 0.35
   • Paper Multicohort study testing the generalisability of the SASKit-ML stroke and PDAC prognostic model pipeline to other chro… DOI 10.1136/bmjopen-2024-088181↗
   • Paper Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidi… DOI 10.1136/bmjopen-2020-039560↗
8. Daniel H. Palmer · 2 shared papers, 2020–2024 · strength 0.35
   • Paper Multicohort study testing the generalisability of the SASKit-ML stroke and PDAC prognostic model pipeline to other chro… DOI 10.1136/bmjopen-2024-088181↗
   • Paper Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidi… DOI 10.1136/bmjopen-2020-039560↗
9. Benjamin Schulz · 2 shared papers, 2022–2024 · strength 0.33
   • Paper Sex Matters-Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer. DOI 10.3390/cancers16101901↗
   • Paper Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Li… DOI 10.3390/cancers14184467↗
10. Olaf Wolkenhauer A · 2 shared papers, 2020–2023 · strength 0.24
    • Paper Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice. DOI 10.1016/j.hbpd.2022.12.003↗
    • Paper Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidi… DOI 10.1136/bmjopen-2020-039560↗
11. Tim Schreiber · 1 shared paper, 2024 · strength 0.20
    • Paper Sex Matters-Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer. DOI 10.3390/cancers16101901↗
12. Brigitte Vollmar · 1 shared paper, 2024 · strength 0.20
    • Paper Sex Matters-Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer. DOI 10.3390/cancers16101901↗
13. Denis Revskij · 1 shared paper, 2023 · strength 0.15
    • Paper Uncoupling protein 2 deficiency of non-cancerous tissues inhibits the progression of pancreatic cancer in mice. DOI 10.1016/j.hbpd.2022.12.003↗
14. Falko Lange · 1 shared paper, 2020 · strength 0.09
    • Paper Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidi… DOI 10.1136/bmjopen-2020-039560↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.